Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Cardiac Resynchronization Therapy in Pediatric Patients and Congenital Heart Disease: What Issues Remain to Solve?

  • June Huh (Division of Cardiology, Department of Pediatrics, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2022.10.20
  • Accepted : 2022.11.02
  • Published : 2022.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Shin HJ, Park YH, Cho BK. Recent surgical outcomes of congenital heart disease according to Korea Heart Foundation data. Korean Circ J 2020;50:677-90.
  2. Diller GP, Kempny A, Alonso-Gonzalez R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation 2015;132:2118-25.
  3. Ahn JE, Kim ST, Kwon HW, et al. Late outcomes of pediatric and congenital heart disease patients following cardiac resynchronization therapy. Korean Circ J 2022;52:865-75.
  4. Janousek J, Gebauer RA, Abdul-Khaliq H, et al. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart 2009;95:1165-71.
  5. Kim M, Kim TH. Finding cardiac resynchronization therapy responders: postprocedural QRS-T morphologies matter. Korean Circ J 2020;50:1074-6.
  6. Miyazaki A, Negishi J, Hayama Y, et al. Evaluating the response to cardiac resynchronization therapy performed with a new ventricular morphology-based strategy for congenital heart disease. Heart Vessels 2019;34:1340-50.